Latest News

April 26, 2021

Press Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers

October 13, 2020

Press Release: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

January 7, 2020

Press Release: NCI-MATCH finds that T-DM1 shows promising activity in salivary gland cancer

December 19, 2019

Press Release: NCI-MATCH finds promising signal for nivolumab beyond colorectal cancer

June 3, 2019

Press Release: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

November 12, 2018

Press Release: NCI-MATCH precision medicine cancer trial enrolling 7-8 new patients weekly

June 4, 2018

Press Release: NCI-MATCH precision medicine clinical trial releases new findings

June 3, 2018

Press Release: TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

September 26, 2017

Press Release: NCI-funded TMIST study compares 2-D and 3-D mammography for finding breast cancers


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
41

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group